Premium
Reversal of rocuronium‐induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy
Author(s) -
De BOER HANS D.,
Van ESMOND JAN,
BOOIJ LEO H.J.D.,
DRIESSEN JACQUES J.
Publication year - 2009
Publication title -
pediatric anesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.704
H-Index - 82
eISSN - 1460-9592
pISSN - 1155-5645
DOI - 10.1111/j.1460-9592.2009.03178.x
Subject(s) - rocuronium , sugammadex , medicine , duchenne muscular dystrophy , anesthesia , muscular dystrophy , neuromuscular blockade , block (permutation group theory) , neuromuscular disease , neuromuscular junction , neuromuscular monitoring , adverse effect , pharmacology , intubation , geometry , mathematics , disease , neuroscience , biology
Summary A case is reported in which a child with Duchenne muscular dystrophy received a dose of sugammadex to reverse a rocuronium‐induced profound neuromuscular block. Sugammadex is the first selective relaxant binding agent and reverses rocuronium‐ and vecuronium‐induced neuromuscular block. A fast and efficient recovery from profound neuromuscular block was achieved, and no adverse events or other safety concerns were observed.